The Inspira Health Primary Care Heart Failure (PCHF) Service is a Consultant-led / GP with Specialist Interest in Cardiology service that provides expert resource to work within GP practices.
The service, which is fully funded, provides a high quality, systematic and seamless pathway to identify, diagnose and treat patients with Heart Failure (HF) with severe Left Ventricular Systolic Dysfunction (LVSD)
Benefits are as follows:
- Ensures patients with HF (with LVSD) are optimally managed and treated to improve health outcomes
- Ensures practices are compliant with NICE guidelines (e.g. TA314, CG108)
- The service is led by a Consultant Cardiologist
- Increases clinicians’ knowledge around evidence-based strategies for managing and treating HF and LVSD
- Delivers HF QOF indicators to their maximum thresholds
- Increases the data quality of the HF and LVSD register
Key results so far:
- PCHF patient clinical reviews have found 24% appropriate for complex device therapy and 45% require medicines optimisation
- PCHF audits have increased LVSD coding by 47%
PCHF Approach
Phase 1: PRIMIS Suite of Audits
- The service installs PRIMIS CHART software and generates MIQUEST queries from the GRASP-HF audit. The queries are then run on the GP Practice clinical system
Phase 2: Patient Medical Records Review (Clinical Audit)
- Audit 1 – Assessing the practice HF and LVSD prevalence
- Audit 2 – Assessing current management and compliance with NICE guidelines (e.g. TA314 and CG108)
Phase 3: Patient Invitations
- Inspira invites all eligible patients to attend a specialist review with a local Consultant at local GP Practice
Phase 4: Consultant Clinic
- Cardiologists review patients for consideration for pharmacological and/or interventional therapy in clinic at the practice. Patients will have up to date ECGs arranged prior to seeing Cardiologist. Patients are referred by the Cardiologist if deemed necessary into secondary/tertiary care for device management and/or treatment optimisation
Phase 5: Patient Follow-up
- Inspira reviews recommendations and subsequent actions at 3-months, 6-months, 9-months and 12-months post clinic to determine outcomes
